港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药外包概念

2,461.148

+78.8533.31%

涨家数：6

跌家数：2

平家数：- -

市盈率：- -

高：2,534.056

开：2,382.859

低：2,375.883

收：2,382.295

数据加载中...

港股异动 | 开拓药业-B(09939.HK)盘中涨超7% 治疗中国男性脱发药物临床试验II期达到主要终点

港股异动 | 云顶新耀(01952)涨超3% EVM14临床试验申请获受理为自研mRNA平台首个实现“中美双报”产品

【湾区早参】广州上半年货物贸易进出口总额首次突破6000亿；东莞今年上半年GDP同比增长4.8%

重发-BRIEF-中国药明生物称预计上半年收益将增长16%，净利同比增56%

药明生物拟8月19日举行董事会会议批准中期业绩

药明生物发盈喜，预期上半年归属于公司权益股东的利润同比增长约56%

药明生物：预期与去年同期比较上半年收益增长约16%

开拓药业-B(09939)：KX- 826 酊1.0%治疗中国成年男性雄激素脱发关键性临床试验II期阶段达到主要终点

港交所消息：7月18日，贝莱德对药明生物H股的多头持仓比例从5.33%增至6.0

每日卖空追踪 | 药明生物 07月23日卖空量成交755.7万股，卖空比例为6.39%

每日卖空追踪 | 金斯瑞生物科技 07月23日卖空量成交385.2万股，卖空比例为7.42%

方达控股07月23日获主力加仓42.1万元

华东医药(000963.SZ)子公司HDM1002片药品临床试验申请获美国FDA批准

港股异动 | CRO概念股早盘走强海外CRO企业二季度业绩超预期机构称板块有望迎来戴维斯双击

百亿基金阵营缩至4只，中欧时代先锋居第三！年内收益12.66%，二季度大调仓，宁德时代成第一重仓

上半年盈利翻倍！CXO强劲反弹，昭衍新药飙升8%！A股最大医疗ETF（512170）冲高2%再刷阶段新高

维亚生物盘中异动大幅拉升5.33%

康龙化成盘中异动早盘股价大涨5.12%报18.900港元

药明康德盘中异动早盘大幅拉升3.06%报94.450港元

药明生物盘中异动股价大涨3.39%报28.950港元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1576/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"医药外包概念","latestPrice":2461.148,"timestamp":1753430886160,"preClose":2382.2947,"halted":0,"volume":202568720,"delay":0,"changeRate":0.0331,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":78.853271,"latestTime":"07-25 16:00:00","open":2382.8591,"high":2534.0562,"low":2375.8826,"amount":6024679434.2,"amplitude":0.066395,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753407000000,1753416000000],[1753419600000,1753430400000]],"pbRate":2.905027,"peRate":13.881935,"turnoverRate":0.017592,"increases":6,"decrements":2,"flats":0,"marketCap":558178889472,"floatMarketCap":227049556480},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2534.0562,"amplitude":0.066395,"preClose":2382.2947,"low":2375.8826,"pbRate":"2.905027","latestPrice":2461.148,"volume":202568720,"delay":0,"open":2382.8591,"prevYearClose":1395.7731,"prevWeekClose":2262.402,"prevMonthClose":1988.255,"prevQuarterClose":1988.255,"fiveDayClose":2262.402,"twentyDayClose":1938.457,"sixtyDayClose":1672.916,"secType":"PLATE","market":"HK","turnoverRate":0.017592,"peRate":13.881935,"marketCap":558178889472,"floatMarketCap":227049556480,"timestamp":1753430886160,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":6,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553222088","title":"港股异动 | 开拓药业-B(09939.HK)盘中涨超7% 治疗中国男性脱发药物临床试验II期达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222088","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553222088?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 10:10","pubTimestamp":1753323003,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1515","BK1141","09939","BK1574","BK1576","03347","BK1161","BK1583"],"gpt_icon":0},{"id":"2553222300","title":"港股异动 | 云顶新耀(01952)涨超3% EVM14临床试验申请获受理 为自研mRNA平台首个实现“中美双报”产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222300","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553222300?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 09:48","pubTimestamp":1753321723,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，云顶新耀涨超3%，截至发稿，涨3.54%，报73.2港元，成交额1.15亿港元。消息面上，7月15日，云顶新耀宣布，其通用型的现货肿瘤治疗性疫苗EVM14注射液的新药临床试验申请获国家药品监督管理局药品审评中心的正式受理。作为云顶新耀首款自研mRNA肿瘤治疗性疫苗，EVM14在临床前研究中展现出巨大治疗潜力。同时，EVM14还能够诱导免疫记忆，展现出有效降低肿瘤复发及转移的能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321330.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01952","BK1161","BK1576","BK1574","BK1141","BK1583","03347"],"gpt_icon":0},{"id":"2553222996","title":"【湾区早参】广州上半年货物贸易进出口总额首次突破6000亿；东莞今年上半年GDP同比增长4.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222996","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553222996?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 08:25","pubTimestamp":1753316706,"startTime":"0","endTime":"0","summary":"根据广东省地区生产总值统一核算结果，2025年上半年，东莞市地区生产总值6067.84亿元，按不变价格计算，同比增长4.8%。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962756","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0819121731.USD","LU0856984785.SGD","LU0228659784.USD","LU0417516738.SGD","LU0327786744.USD","LU0181495838.USD","LU0328353924.USD","MUCmain","BK1576","LU1242518931.SGD","BK4588","LU0823426480.USD","LVS","LU0228367735.SGD","LU0594300419.USD","LU0128522157.USD","LU0543330483.HKD","LU1880383366.USD","LU0708995583.HKD","LU2125910500.SGD","LU0072462343.USD","LU0456846285.SGD","02269","LU0348825331.USD","80020","LU0385154629.USD","IE0009570106.USD","LU0320764755.SGD","LU2045819591.USD","IE00BFXG1179.USD","CYB","HK0000306701.USD","LU0516422366.SGD","LU0823426308.USD","CNHmain","HK0000320223.HKD","MCNHmain","00020","LU1794554557.SGD","03931","02319","UCmain","BK1109","02550","LU0417516902.SGD","LU0651946864.USD","LU1769817179.HKD","LU0516423174.USD","LU0052750758.USD"],"gpt_icon":1},{"id":"2553222622","title":"重发-BRIEF-中国药明生物称预计上半年收益将增长16%，净利同比增56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222622","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553222622?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 08:03","pubTimestamp":1753315412,"startTime":"0","endTime":"0","summary":"重发-BRIEF-中国药明生物称预计上半年收益将增长16%，净利同比增56%重发以补上标题前半句百分号路透7月24日 - WuXi Biologics (Cayman) Inc 2269.HK:中国药明生物称预计上半年收益将增长约16%；毛利率将同比提升约3.6%；预计上半年利润及归属于公司权益股东的利润同比分别增长约54%和56%。浏览详情，请点击此处 (发稿 崔珠珠) ((Zhuzhu.Cui@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nL4T3TL00G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","LU0140636845.USD","LU1242518931.SGD","LU0856984785.SGD","LU0456846285.SGD","LU2039709279.SGD","BK1521","IE00B0JY6N72.USD","LU0326950275.SGD","LU0051755006.USD","LU0327786744.USD","LU0979878070.USD","LU0516422366.SGD","LU0039217434.USD","LU0359201612.USD","LU0588546209.SGD","LU0181495838.USD","LU0516422952.EUR","LU0516423091.SGD","LU1720050803.USD","LU1794554557.SGD","SG9999002463.SGD","LU0516423174.USD","LU0823426308.USD","LU0708995583.HKD","LU0348825331.USD","LU0819121731.USD","SG9999002562.SGD","LU0043850808.USD","LU0456827905.SGD","BK1589","LU0307460666.USD","LU0320764599.SGD","BK1610","LU0417516902.SGD","LU0572944931.SGD","BK1576","LU0359202008.SGD","LU0052750758.USD","LU0823426480.USD","BK1141","02269","LU0417516738.SGD","LU1242518857.USD","LU0348735423.USD","LU0516422440.USD","LU1688375341.USD"],"gpt_icon":0},{"id":"2553801226","title":"药明生物拟8月19日举行董事会会议批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2553801226","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553801226?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 07:19","pubTimestamp":1753312797,"startTime":"0","endTime":"0","summary":"格隆汇7月24日丨药明生物(02269.HK)宣布，公司谨订于2025年8月19日（星期二）在香港举行董事会会议，藉以（其中包括）考虑及批准集团截至2025年6月30日止六个月的中期业绩及其刊发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724072010971ab4bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724072010971ab4bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1880383366.USD","LU0140636845.USD","LU1242518931.SGD","LU0856984785.SGD","LU0456846285.SGD","LU2039709279.SGD","BK1521","IE00B0JY6N72.USD","LU0326950275.SGD","LU0051755006.USD","LU0327786744.USD","LU0979878070.USD","LU0516422366.SGD","LU0039217434.USD","LU0359201612.USD","LU0588546209.SGD","LU0181495838.USD","LU0516422952.EUR","LU0516423091.SGD","LU1720050803.USD","LU1794554557.SGD","SG9999002463.SGD","LU0516423174.USD","LU0823426308.USD","LU0708995583.HKD","LU0348825331.USD","LU0819121731.USD","SG9999002562.SGD","LU0043850808.USD","LU0456827905.SGD","BK1589","LU0307460666.USD","LU0320764599.SGD","BK1610","LU0417516902.SGD","LU0572944931.SGD","BK1576","LU0359202008.SGD","LU0052750758.USD","LU0823426480.USD","WXIBF","BK1141","02269","LU0417516738.SGD","LU1242518857.USD","LU0348735423.USD","LU0516422440.USD","LU1688375341.USD"],"gpt_icon":0},{"id":"2553225058","title":"药明生物发盈喜，预期上半年归属于公司权益股东的利润同比增长约56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553225058","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553225058?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 07:08","pubTimestamp":1753312137,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明生物 公布，该集团预期于2025年上半年取得的收益同比将增长约16%;毛利率将同比提升约3.6%;利润及归属于公司权益股东的利润相比于去年同期将分别增长约54%和约56%;以及经调整股份为基础的薪酬开支、外汇损益及股权投资损益后，公司非国际财务报告准则经调整纯利将增长约11%。","market":"us","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"aafa41a61db4c8d521e55fc890d73ff0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321269.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药明生物发盈喜，预期上半年归属于公司权益股东的利润同比增长约56%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1521","LU0516423174.USD","LU0823426480.USD","LU1794554557.SGD","LU0140636845.USD","LU0327786744.USD","LU1688375341.USD","LU1242518857.USD","LU2039709279.SGD","LU0417516738.SGD","LU0326950275.SGD","BK1576","IE00B0JY6N72.USD","LU0359202008.SGD","LU0516422440.USD","LU0516422952.EUR","LU0348735423.USD","LU0348825331.USD","LU1880383366.USD","LU0359201612.USD","BK1589","LU1242518931.SGD","LU0039217434.USD","LU0417516902.SGD","LU0708995583.HKD","SG9999002463.SGD","LU0856984785.SGD","LU0979878070.USD","LU0456846285.SGD","LU0588546209.SGD","LU0181495838.USD","LU0043850808.USD","LU0823426308.USD","LU0516423091.SGD","BK1610","LU0572944931.SGD","SG9999002562.SGD","LU0516422366.SGD","LU0320764599.SGD","LU0051755006.USD","LU0052750758.USD","LU0819121731.USD","LU0456827905.SGD","LU0307460666.USD","LU1720050803.USD","02269"],"gpt_icon":1},{"id":"2553225706","title":"药明生物：预期与去年同期比较上半年收益增长约16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553225706","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553225706?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 07:08","pubTimestamp":1753312135,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0348825331.USD","LU0516423174.USD","HEXmain","LU0052750758.USD","IE00B0JY6N72.USD","LU0320764599.SGD","LU0516422366.SGD","LU0456827905.SGD","LU0417516902.SGD","SG9999002562.SGD","LU1720050803.USD","BK1521","LU0359202008.SGD","LU0359201612.USD","BK1141","LU0572944931.SGD","LU0588546209.SGD","LU0856984785.SGD","LU0043850808.USD","LU0516423091.SGD","LU1794554557.SGD","LU0979878070.USD","SG9999002463.SGD","LU0516422952.EUR","LU1242518857.USD","LU0348735423.USD","LU0516422440.USD","LU0708995583.HKD","LU0823426308.USD","LU0307460666.USD","LU0327786744.USD","LU0819121731.USD","BK1610","LU0456846285.SGD","LU1242518931.SGD","BK1589","LU0417516738.SGD","LU0823426480.USD","LU0181495838.USD","LU0326950275.SGD","BK1576","LU0051755006.USD","LU0140636845.USD","LU2039709279.SGD","LU0039217434.USD","LU1688375341.USD","02269","LU1880383366.USD"],"gpt_icon":0},{"id":"2553922531","title":"开拓药业-B(09939)：KX- 826 酊1.0%治疗中国成年男性雄激素脱发关键性临床试验II期阶段达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2553922531","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553922531?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 06:15","pubTimestamp":1753308950,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开拓药业-B 公布，其自主研发、潜在同类首创的 KX-826 酊 1.0%治疗脱发的关键性临床试验 II 期阶段已获得顶线数据。该项关键性临床试验是一项多中心、随机、双盲、赋形剂对照的 II/III 期适应性设计研究，用以评估 KX-826 酊 1.0%和 0.5%外用治疗中国成年男性 AGA 患者的有效性和安全性。与安慰剂组相比，0.5% BID组和 1.0% BID 组均显示出统计学显著的 疗效优势及临床意义 。KX-826 酊在临床试验显示出令人满意的安全性和耐受性，整体不良事件发生率低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","03347","BK1161","BK1583","BK1141","BK1515","09939","BK1576"],"gpt_icon":0},{"id":"2553249943","title":"港交所消息：7月18日，贝莱德对药明生物H股的多头持仓比例从5.33%增至6.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2553249943","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553249943?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 19:51","pubTimestamp":1753271509,"startTime":"0","endTime":"0","summary":"港交所消息：7月18日，贝莱德对 药明生物 （02359.HK）H股的多头持仓比例从5.33%增至6.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723225558a6bdabb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723225558a6bdabb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0588546209.SGD","LU0327786744.USD","LU0456846285.SGD","02359","LU0052750758.USD","SG9999002562.SGD","WXIBF","LU0043850808.USD","LU0979878070.USD","LU0320764599.SGD","LU0456827905.SGD","LU0823426480.USD","LU1242518857.USD","02269","LU1688375341.USD","LU0516422440.USD","BK1521","LU0708995583.HKD","LU0348825331.USD","LU1880383366.USD","SG9999002463.SGD","BK1141","LU0326950275.SGD","LU0359201612.USD","LU0516422366.SGD","LU2039709279.SGD","LU0359202008.SGD","LU0516422952.EUR","LU0140636845.USD","LU0823426308.USD","BK1576","LU1046422090.SGD","LU0417516738.SGD","LU0039217434.USD","LU2125910500.SGD","LU0417516902.SGD","IE00B0JY6N72.USD","LU0348735423.USD","LU0516423174.USD","LU1794554557.SGD","LU2242644610.SGD","LU0307460666.USD","LU2045819591.USD","LU0819121731.USD","LU1720050803.USD","LU0572944931.SGD","BK1583","LU0181495838.USD","BK1589","LU0856984785.SGD","BK1610"],"gpt_icon":0},{"id":"2553142622","title":"每日卖空追踪 | 药明生物 07月23日卖空量成交755.7万股，卖空比例为6.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553142622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553142622?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 16:30","pubTimestamp":1753259427,"startTime":"0","endTime":"0","summary":"药明生物北京时间07月23日，涨2.68%，卖空量成交755.7万股%，较上一交易日增加45.87%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723172151a45e86dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723172151a45e86dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516902.SGD","LU0819121731.USD","BK1521","LU0516422952.EUR","SG9999002562.SGD","LU0181495838.USD","LU0823426480.USD","LU0327786744.USD","LU0979878070.USD","BK1576","LU1242518857.USD","SG9999002463.SGD","LU0348825331.USD","LU0326950275.SGD","BK1610","LU1688375341.USD","LU0307460666.USD","LU0051755006.USD","LU0516422366.SGD","LU0456846285.SGD","LU0516422440.USD","LU0856984785.SGD","LU1242518931.SGD","LU1880383366.USD","LU2039709279.SGD","LU0823426308.USD","LU1794554557.SGD","02269","LU0516423174.USD","BK1141","LU0320764599.SGD","LU1720050803.USD","LU0140636845.USD","LU0359201612.USD","IE00B0JY6N72.USD","LU0708995583.HKD","LU0039217434.USD","LU0348735423.USD","LU0043850808.USD","LU0052750758.USD","LU0456827905.SGD","BK1589","LU0516423091.SGD","LU0572944931.SGD","LU0417516738.SGD","LU0588546209.SGD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2553167132","title":"每日卖空追踪 | 金斯瑞生物科技 07月23日卖空量成交385.2万股，卖空比例为7.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553167132","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553167132?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 16:30","pubTimestamp":1753259421,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技北京时间07月23日，涨6.7%，卖空量成交385.2万股%，较上一交易日减少28.64%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723171941a6bcf9f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723171941a6bcf9f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","HK0000306685.HKD","HK0000320264.USD","BK1576","HK0000320223.HKD","HK0000306701.USD","01548"],"gpt_icon":0},{"id":"2553954213","title":"方达控股07月23日获主力加仓42.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553954213","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553954213?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 16:16","pubTimestamp":1753258561,"startTime":"0","endTime":"0","summary":"07月23日, 方达控股股价涨15.94%，报收1.60元，成交金额454.7万元，换手率0.14%，振幅19.57%，量比2.32。方达控股今日主力资金净流入42.1万元，上一交易日主力净流入13.9万元。该股近5个交易日上涨35.59%，主力资金累计净流入95.6万元；近20日主力资金累计净流入87.5万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723170537a6bcf034&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723170537a6bcf034&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01521","BK1141","BK1576"],"gpt_icon":0},{"id":"2553297328","title":"华东医药(000963.SZ)子公司HDM1002片药品临床试验申请获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2553297328","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553297328?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 15:51","pubTimestamp":1753257118,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华东医药(000963.SZ)发布公告，2025年07月22日，公司全资子公司杭州中美华东制药有限公司(简称“中美华东”)收到美国食品药品监督管理局(简称“美国FDA”)通知，由中美华东申报的HDM1002片药品临床试验申请已获得美国FDA批准。HDM1002是由中美华东自主研发并拥有全球知识产权的创新型小分子药物，是具有口服活性、强效、高选择性的GLP-1受体小分子完全激动剂。HDM1002可强效激活GLP-1受体，诱导环磷酸腺苷(cAMP)产生，具有强效的改善糖耐受、降糖和减重作用并且显示出良好的安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","03347","BK0175","BK1576","LU1969619763.USD","BK0187","BK0188","BK1583","LU2328871848.SGD","BK0209","BK1141","BK0183","000963","BK0132"],"gpt_icon":0},{"id":"2553933032","title":"港股异动 | CRO概念股早盘走强 海外CRO企业二季度业绩超预期 机构称板块有望迎来戴维斯双击","url":"https://stock-news.laohu8.com/highlight/detail?id=2553933032","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553933032?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 11:13","pubTimestamp":1753240394,"startTime":"0","endTime":"0","summary":"消息面上，美东时间周二，海外CRO企业Medpace股价跳空高开逾44%，早盘涨幅一度扩大到62.3%，后涨幅有所收窄，收涨近54.7%，创收盘最高纪录，并创上市将近九年来最大单日涨幅。中泰证券指出，7月10日，CRO、CDMO龙头公司药明康德及博腾股份发布中报业绩预告，其中药明康德2025年上半年经调整归母净利润约63.1亿元，同比增长44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0856984785.SGD","BK1583","BK1610","LU0516422366.SGD","LU0327786744.USD","BK1521","LU0516422952.EUR","01548","LU0043850808.USD","02269","LU0516422440.USD","LU0456846285.SGD","LU0819121731.USD","LU1242518931.SGD","LU1688375341.USD","LU0051755006.USD","LU2039709279.SGD","LU0572944931.SGD","LU0516423091.SGD","LU0823426480.USD","HK0000320223.HKD","LU0181495838.USD","LU0348825331.USD","LU0320764599.SGD","03759","LU0359202008.SGD","LU0516423174.USD","LU1794554557.SGD","BK1589","LU0039217434.USD","SG9999002463.SGD","BK1141","HK0000306685.HKD","01521","LU1720050803.USD","LU0052750758.USD","LU0140636845.USD","LU0307460666.USD","LU0979878070.USD","HK0000320264.USD","HK0000306701.USD","BK1191","LU0326950275.SGD","LU0588546209.SGD","SG9999002562.SGD","06821","06127","BK1576","IE00B0JY6N72.USD","LU0823426308.USD"],"gpt_icon":0},{"id":"2553293024","title":"百亿基金阵营缩至4只，中欧时代先锋居第三！年内收益12.66%，二季度大调仓，宁德时代成第一重仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2553293024","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553293024?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 11:04","pubTimestamp":1753239840,"startTime":"0","endTime":"0","summary":"尽管规模有所变动，但今年以来，截至7月22日，中欧时代先锋却展现出了强劲的业绩表现，年内收益率达到12.66%，在市场中脱颖而出，吸引了众多投资者的目光。中欧基金作为中欧时代先锋的发行方，在公募市场中也占据着重要地位，截至2025年二季度数据，公司整体规模逆势增长至6138.5亿元，但权益类产品仍需直面ETF的分流压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723114548954e0022&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723114548954e0022&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","BK1583","603986","LU0708995583.HKD","LU2045819591.USD","LU2242644610.SGD","BK1116","03750","LU2125910500.SGD","603259","02359","LU0320764599.SGD","BK1141","BK1576","LU0052750758.USD"],"gpt_icon":1},{"id":"2553588298","title":"上半年盈利翻倍！CXO强劲反弹，昭衍新药飙升8%！A股最大医疗ETF（512170）冲高2%再刷阶段新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2553588298","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553588298?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 10:13","pubTimestamp":1753236780,"startTime":"0","endTime":"0","summary":"医疗板块突围进行时！7月23日早盘，CXO概念强势反弹，昭衍新药劲涨超8%，康龙化成涨超6%，凯莱英、九洲药业、泰格医药、药明康德等均大幅跟涨。　　A股最大医疗ETF盘中上探2%，盘中价再刷近4个月新高！场内交投活跃，开盘30分钟成交额突破4亿元。　　消息面，日前多家CXO龙头企业中报业绩预喜。昭衍新药上半年净利最高预增144%，药明康德亦预增超100%，康龙化成最高预增11%。　　还看好创新药，可以关注国内首只药ETF。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-07-23/doc-infhmnxu1352698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1576","CXO","159982","399300","512170","BK1141","06127","159828","603127","BK0216"],"gpt_icon":0},{"id":"2553677862","title":"维亚生物盘中异动 大幅拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553677862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553677862?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 09:46","pubTimestamp":1753235203,"startTime":"0","endTime":"0","summary":"2025年07月23日早盘09时46分，维亚生物股票出现异动，股价快速上涨5.33%。截至发稿，该股报1.580港元/股，成交量202.451万股，换手率0.10%，振幅4.67%。资金方面，该股资金流入269.366万港元，流出32.1795万港元。维亚生物股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，方达控股、三叶草生物-B、乐普生物-B涨幅较大，振幅较大的相关个股有方达控股、三叶草生物-B、乐普生物-B，振幅分别为19.57%、15.69%、12.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094643a6bc12cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094643a6bc12cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01873","BK1141","BK1576"],"gpt_icon":0},{"id":"2553267723","title":"康龙化成盘中异动 早盘股价大涨5.12%报18.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553267723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553267723?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 09:38","pubTimestamp":1753234719,"startTime":"0","endTime":"0","summary":"2025年07月23日早盘09时38分，康龙化成股票出现异动，股价急速拉升5.12%。截至发稿，该股报18.900港元/股，成交量488.81万股，换手率1.66%，振幅4.00%。资金方面，该股资金流入3898.63万港元，流出3118.11万港元。康龙化成股票所在的药品行业中，整体涨幅为0.50%。其相关个股中，华控康泰、励晶太平洋、艾美疫苗涨幅较大，振幅较大的相关个股有君圣泰医药-B、精优药业、翰森制药，振幅分别为9.94%、7.50%、6.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093839a45d9380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093839a45d9380&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","03759","BK1141"],"gpt_icon":0},{"id":"2553260121","title":"药明康德盘中异动 早盘大幅拉升3.06%报94.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553260121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553260121?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 09:30","pubTimestamp":1753234236,"startTime":"0","endTime":"0","summary":"2025年07月23日早盘09时30分，药明康德股票出现波动，股价急速拉升3.06%。截至发稿，该股报94.450港元/股，成交量31.8065万股，换手率0.08%，振幅0.87%。资金方面，该股资金流入1256.9万港元，流出874.672万港元。药明康德股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，奥星生命科技、三叶草生物-B、药明合联涨幅较大，振幅较大的相关个股有三叶草生物-B、泰格医药、中国抗体-B，振幅分别为9.80%、3.93%、3.31%。本次权益分派除权除息日为2025年7月29日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093036a6bc08af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093036a6bc08af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU0320764599.SGD","BK1576","LU2242644610.SGD","BK1583","02359","LU2045819591.USD","LU0708995583.HKD","BK1141","LU2125910500.SGD","LU0052750758.USD"],"gpt_icon":0},{"id":"2553267730","title":"药明生物盘中异动 股价大涨3.39%报28.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553267730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553267730?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 09:30","pubTimestamp":1753234205,"startTime":"0","endTime":"0","summary":"2025年07月23日早盘09时30分，药明生物股票出现波动，股价大幅上涨3.39%。截至发稿，该股报28.950港元/股，成交量155.6万股，换手率0.04%，振幅0.71%。资金方面，该股资金流入1097.01万港元，流出628.47万港元。药明生物股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，奥星生命科技、药明合联、方达控股涨幅较大，振幅较大的相关个股有荣昌生物、诺诚健华、康宁杰瑞制药-B，振幅分别为0.00%、0.00%、0.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093005a6bc0811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093005a6bc0811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0516422440.USD","BK1589","LU0572944931.SGD","LU1688375341.USD","LU0039217434.USD","LU0327786744.USD","LU0456827905.SGD","02269","LU0417516902.SGD","LU0516422366.SGD","LU0043850808.USD","LU0588546209.SGD","LU0819121731.USD","LU0516423091.SGD","LU0979878070.USD","LU0348735423.USD","LU0417516738.SGD","LU0516423174.USD","BK1576","LU2039709279.SGD","LU0823426480.USD","BK1521","SG9999002562.SGD","BK1141","LU0307460666.USD","LU0140636845.USD","LU0348825331.USD","LU0708995583.HKD","LU1794554557.SGD","LU0359201612.USD","LU1242518857.USD","LU0320764599.SGD","SG9999002463.SGD","LU0516422952.EUR","LU0856984785.SGD","IE00B0JY6N72.USD","BK1610","LU0823426308.USD","LU0359202008.SGD","LU0456846285.SGD","LU0181495838.USD","LU0051755006.USD","LU0326950275.SGD","LU1720050803.USD","LU1880383366.USD","LU1242518931.SGD","LU0052750758.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":187,"code":"91000000","status":"200"}]}}